The US Food and Drug Administration Dual Mandate for Rapid Drug Review and Equity

JAMA Netw Open. 2024 May 1;7(5):e2411447. doi: 10.1001/jamanetworkopen.2024.11447.

Authors

Rebecca A Miksad¹, Cleo A Ryals²

Affiliations

¹ Boston Medical Center, Boston University, Boston, Massachusetts.
² Flatiron Health, New York, New York.

PMID: 38691364
DOI: 10.1001/jamanetworkopen.2024.11447

No abstract available

MeSH terms

Drug Approval / legislation & jurisprudence
Health Equity
Humans
United States
United States Food and Drug Administration*